Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Patient-Centered Insights on MRD Negativity: Efficacy, Regulatory Approval, and Treatment Experience in Multiple Myeloma
About
This study, led by Dr. Carl Ola Landgren, explores multiple myeloma patients' perceptions of MRD negativity, including its significance for treatment success, access to novel therapies, and its role in clinical trial endpoints.
12 minutes
C. Ola Landgren, M.D., Ph.D., University of Miami
Details
Contact Information
For any questions or concerns regarding the study, participants can contact HealthTree Patient Navigators at support@healthtree.org.